Because Truveta Data provides the most complete, timely, and clean de-identified EHR data, including full patient medical records, notes, and images, linked with claims, SDOH, and mortality data for more than 100 million patients across the US, we can show the latest trends in these medications, including the early uptake in tirzepatide labeled for obesity (Zepbound), which was approved by the FDA in November 2023
Before you can inject, you must reconstitute the powder into an injectable solution using bacteriostatic water
& Keating, G
For patients who cannot take stimulants unlike phentermine, Contrave is non-stimulant
Let's transform expertise into influence